Hormone Replacement Therapy Research Today is a free monthly online journal that collates and summarizes the latest research about Hormone Replacement Therapy, including details on hrt, menopause, natural hrt, effects, risks.

Volume 4 (2007), Issue 4 (April)

1. The influence of HRT on technical recall in the UK Breast Screening Programme: are pain, compression force, and compressed breast thickness contributing factors?
   Clin Radiol, 62(5): 439-46. [Abstract] [Full-text]
2. Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
   Int J Cancer, 120(10): 2202-7. [Abstract] [Full-text]
3. Response to SSRIs and role of the hormonal therapy in post-menopausal depression.
   Eur Neuropsychopharmacol, 17(6): 400-5. [Abstract] [Full-text]
4. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
   Am J Obstet Gynecol, 196(4): 342.e1-9. [Abstract] [Full-text]
5. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
   JAMA, 297(13): 1465-77. [Abstract] [Full-text]
6. Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice.
   J Appl Physiol, 102(4): 1387-93. [Abstract] [Full-text]
7. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
   Cancer Epidemiol Biomarkers Prev, 16(4): 723-30. [Abstract] [Full-text]
8. Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain.
   Neurosci Lett, 417(1): 50-4. [Abstract] [Full-text]
9. Postmenopausal hormone therapy and changes in mammographic density.
   J Clin Oncol, 25(11): 1323-8. [Abstract] [Full-text]
10. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
    Growth Horm IGF Res, 17(2): 149-53. [Abstract] [Full-text]
11. Adult growth hormone deficiency: to treat or not to treat.
    Expert Opin Pharmacother, 8(6): 787-95. [Abstract] [Full-text]
12. Glucocorticoid replacement therapy in patients with Addison's disease.
    Expert Opin Pharmacother, 8(6): 725-9. [Abstract] [Full-text]
13. Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.
    Fertil Steril, 87(4): 978-81. [Abstract] [Full-text]
14. Sex hormones and thrombosis.
    Semin Hematol, 44(2): 98-105. [Abstract] [Full-text]
15. Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test.
    J Pain, 8(4): 334-42. [Abstract] [Full-text]
16. Mucinous cystadenocarcinoma of the pancreas developing during hormone replacement therapy.
    Dig Dis Sci, 52(5): 1326-8. [Abstract] [Full-text]
17. Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].
    BJOG, 114(5): 548-54. [Abstract] [Full-text]
18. The decrease in breast-cancer incidence in 2003 in the United States.
    N Engl J Med, 356(16): 1670-4. [Abstract] [Full-text]
19. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
    J Bone Miner Res, 22(5): 762-70. [Abstract] [Full-text]
20. DHEA therapy for women: effect on sexual function and wellbeing.
    Hum Reprod Update, 13(3): 239-48. [Abstract] [Full-text]
21. Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.
    Climacteric, 10(2): 155-63. [Abstract] [Full-text]
22. The influence of smoking on uterine bleeding during sequential oral hormone therapy.
    Climacteric, 10(2): 147-54. [Abstract] [Full-text]
23. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
    Climacteric, 10(2): 120-31. [Abstract] [Full-text]
24. Effects of hormone replacement therapy and aging on cognition: evidence for executive dysfunction.
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 14(3): 301-28. [Abstract] [Full-text]
25. Endometrial bleeding during hormone therapy: the effect of progestogens.
    Maturitas, 57(1): 71-6. [Abstract] [Full-text]
26. The problems with some epidemiological studies.
    Maturitas, 57(1): 11-5. [Abstract] [Full-text]
27. Breast cancer: are oestrogen metabolites carcinogenic?
    Maturitas, 57(1): 42-6. [Abstract] [Full-text]
28. HRT and the primary prevention of cardiovascular disease.
    Maturitas, 57(1): 31-4. [Abstract] [Full-text]
29. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Maturitas, 57(1): 81-4. [Abstract] [Full-text]
30. Postmenopausal hormone therapy: the way ahead.
    Maturitas, 57(1): 3-5. [Abstract] [Full-text]
31. The future of postmenopausal hormone therapy: It's time to move forward.
    Maturitas, 57(1): 103-6. [Abstract] [Full-text]
32. WHI risks: any relevance to menopause management?
    Maturitas, 57(1): 6-10. [Abstract] [Full-text]
33. Routes of delivery for progesterone and progestins.
    Maturitas, 57(1): 77-80. [Abstract] [Full-text]
34. Quality of life (QOL) in menopause.
    Maturitas, 57(1): 100-2. [Abstract] [Full-text]
35. Using Internet technologies to improve and simplify counseling about menopause: the WISDOM website.
    Maturitas, 57(1): 95-9. [Abstract] [Full-text]
36. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Am J Epidemiol, 165(10): 1187-98. [Abstract] [Full-text]
37. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.
    Eur J Endocrinol, 156(5): 595-602. [Abstract] [Full-text]

© 2004-2008 Hormone Replacement Therapy Research Today. All Rights Reserved.